Saranya Chumsri

Also affiliated with Mayo Clinic in Florida

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 21 papers. Top paper: “Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer”.

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

Nature Communications(2023)10.1038/s41467-023-37806-0

N/A

1.4DataRank · unranked

44 citations

Saranya Chumsri, Douglas Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh +21 more

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

British Journal of Cancer(2020)10.1038/s41416-020-0786-x

N/A

1.4DataRank · unranked

40 citations

Noam Pondé, Dominique Agbor‐Tarh, Alvaro Moreno‐Aspitia, Martine Piccart, Florentine Hilbers +11 more

Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1945

N/A

0.561DataRank · unranked

41 citations

Heather Ann Brauer, Amy Sullivan, Susanna Lauttia, Henrik Lindman, Torsten O. Nielsen +4 more

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

npj Breast Cancer(2022)10.1038/s41523-022-00430-0

N/A

0.417DataRank · unranked

8 citations

Zhuo Li, Daniel Serie, Nadine Norton, Afshin Mashadi-Hossein, Kathleen Tenner +20 more

Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0341

N/A

0.303DataRank · unranked

4 citations

Vera J. Suman, Karthik V. Giridhar, Kostandinos Sideras, Donald W. Northfelt, Brenda Ernst +15 more

Hyper engorged cancer associated macrophage-like cells in circulation predict for multi-organ metastatic disease in solid tumors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3039

N/A

0.165DataRank · unranked

2 citations

Raymond C. Bergan, Steven H. Lin, R. Katherine Alpaugh, Massimo Cristofanilli, Saranya Chumsri +10 more

Role of intratumoral NK cells in triple-negative breast cancer in the FinXX trial and Mayo Clinic cohort.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.510

N/A

0.165DataRank · unranked

2 citations

Jodi M. Carter, Yaohua Ma, Douglas Hinerfeld, Heather Ann Brauer, Sarah Warren +15 more

Circulating stromal cells as a potential blood-based biomarker for screening invasive solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3535

N/A

0.104DataRank · unranked

1 citations

Steven H. Lin, Harvey I. Pass, Saranya Chumsri, Rena G. Lapidus, Martin J. Edelman +15 more

Clinical Treatment Score Post-5 Years (CTS5) and Late Recurrence Risk in Hormone Receptor–Positive, HER2-Positive Breast Cancer

Journal of the National Comprehensive Cancer Network(2024)10.6004/jnccn.2024.7015

N/A

0.104DataRank · unranked

1 citations

Tanmayi Pai, Yaohua Ma, Zhuo Li, Angelica Gil, Alvaro Moreno‐Aspitia +7 more

Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients

medRxiv(2023)10.1101/2023.03.22.23287597

N/A

0DataRank · unranked

1 citations

Xian Zhou, Yanfeng Li, Jane Jaquith, Kathleen McCarthy-Fruin, Jennifer Sletten +11 more

Sequential monitoring of tumor macrophage fusion cells in the circulation of metastatic breast cancer and their prognostic value.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3054

N/A

0DataRank · unranked

0 citations

Massimo Cristofanilli, Carolina Reduzzi, R. Katherine Alpaugh, Rena G. Lapidus, Saranya Chumsri +7 more

Correlation of micronuclei formation in circulating stromal cells with their PD-L1 expression and predicts for poorer clinical outcomes in metastatic breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e14548

N/A

0DataRank · unranked

0 citations

Massimo Cristofanilli, R. Katherine Alpaugh, Saranya Chumsri, Cha‐Mei Tang, Rena G. Lapidus +6 more

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]

ESMO Open(2024)10.1016/j.esmoop.2024.103938

N/A

0DataRank · unranked

9 citations

M. Piccart-Gebhart, Shona Fielding, John Townend, D.W. Hillman, M. Colleoni +37 more

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

UNC Libraries(2025)10.17615/kfcn-nf74

N/A

0DataRank · unranked

0 citations

Afshin Mashadi-Hossein, Kathleen Tenner, Lisa A. Carey, Zhuo Li, Heather Ann Brauer +20 more

Interferon signaling and outcomes in triple-negative breast cancer (TNBC) in FinXX, CALGB 40603 (Alliance) and real-world clinico-genomic data.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.569

N/A

0DataRank · unranked

0 citations

Yi Liu, Sachin Kumar Deshmukh, Jodi M. Carter, Heikki Joensuu, Roberto A. Leon‐Ferre +15 more

Value of clinical treatment score post-5 years (CTS5) for late relapse risk assessment in patients with early-stage HER2+ breast cancer (BC) in the north central cancer treatment group (NCCTG) N9831 (Alliance) trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.529

N/A

0DataRank · unranked

0 citations

Angelica Gil, Yaohua Ma, Zhuo Li, Pooja Advani, Alvaro Moreno‐Aspitia +5 more

Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination

JAMA Oncology(2021)10.1001/jamaoncol.2021.3127

N/A

0DataRank · unranked

50 citations

Santo Maimone, Denise A. Gococo-Benore, Zhuo Li, Pooja Advani, Saranya Chumsri +1 more

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00452-8

N/A

0DataRank · unranked

13 citations

Lieveke Ameye, Samuel Martel, Philippe Aftimos, Noam Pondé, Christian Maurer +15 more

Effect of mevalonate pathway inhibitors on outcomes of patients (pts) with HER2-positive early breast cancer (BC) in the ALTTO trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.522

N/A

0DataRank · unranked

0 citations

Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Lieveke Ameye, Marianne Paesmans, Sarra El-Abed +13 more

Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients

Frontiers in Immunology(2023)10.3389/fimmu.2023.1224702

N/A

0DataRank · unranked

10 citations

Gabriel Figueroa‐Parra, Xian Zhou, Yanfeng Li, Jane Jaquith, Kathleen McCarthy-Fruin +11 more

The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07159-9

N/A

0DataRank · unranked

2 citations

Marie Kassapian, Véronique Debien, Rafael Caparica, Daniel Eiger, Urania Dafni +12 more